Pricing Log in Create free account

GridAI Technologies Corp. (GRDX) vs Metagenomi Therapeutics, Inc. (MGX)

GridAI Technologies Corp. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. GridAI Technologies Corp. and Metagenomi Therapeutics, Inc. are of similar size ($31.9M and $31.8M). GridAI Technologies Corp. has the higher net margin (0.00% vs −689.2%) and the lower return on invested capital (−79.3% vs 0.00%). Across the 14 metrics below, GridAI Technologies Corp. leads on 8 and Metagenomi Therapeutics, Inc. on 6.

Valuation

Metric GRDX MGX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2.17 9.71
P/B 1.82 0.26 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.63 0.64
EV/Sales n/m (4.50) 9.21
Earnings yield (140.61%) (319.23%) (33.15%)
Free cash flow yield (29.90%) (292.09%) (25.50%)

Profitability

Metric GRDX MGX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (741.58%) 0.00%
Net margin 0.00% (689.20%) 0.00%
Free cash flow margin 0.00% (632.67%) 0.00%
Return on equity (485.88%) (60.61%) (56.36%)
Return on assets (34.14%) (41.91%) (48.04%)
Return on invested capital (79.29%) 0.00% 0.00%

Growth

Metric GRDX MGX Biotechnology median
Revenue growth (TTM) — (59.84%) 6.02%
EPS growth (last fiscal year) 74.65% 0.00% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GRDX MGX Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 0.16 4.50 4.72
Net debt to EBITDA 0.10 1.71 0.96

Dividend

Metric GRDX MGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GRDX MGX Biotechnology median
Market cap 31.81m 31.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack